Stereotaxis Inc. (STXS), a U.S.-based company specializing in surgical robotics for minimally invasive heart and vascular procedures, has signed a definitive agreement to acquire Robocath, a French developer of robotic technologies for interventional cardiology and neurointerventions.
The acquisition combines Stereotaxis' magnetic navigation system with Robocath's mechanical robotic platform, creating a fully integrated solution designed to improve precision and efficiency in endovascular surgery. Robocath's flagship R-One+ system is already in use for coronary interventions in Europe, with fifteen installations worldwide, and its next-generation system recently completed first-in-human procedures in France.
Stereotaxis will pay $20 million upfront, with up to $25 million in contingent payments tied to regulatory and commercial milestones, including FDA clearance of Robocath's next generation system. The deal is expected to close in mid-2026, after which Robocath will operate as a wholly owned subsidiary of Stereotaxis.
"This acquisition amplifies our strategy as the leading robotic platform for endovascular procedures," said David Fischel, Chairman and CEO of Stereotaxis. "By combining complementary technologies, we accelerate innovation, expand our reach, and open new avenues for growth."
Stereotaxis estimates Robocath will contribute about $2 million in revenue in its first-year post-acquisition, with breakeven expected by year three, supported by commercial synergies.
STXS has traded between $1.69 and $3.59 over the past year. The stock closed Tuesday's trading at $2.03, up 5.73%. In pre-market trading the stock is at $2.05, up 1.67%.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.